Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome
- PMID: 22018243
- PMCID: PMC3308105
- DOI: 10.1186/ar3493
Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome
Abstract
Introduction: In this study, we investigated possible aberrations of monocytes from patients with primary Sjögren's syndrome (pSS). We focused on B-cell-activating factor of the TNF family (BAFF) and IL-6 because they are both produced by monocytes and are known to be involved in the pathogenesis of pSS.
Methods: Peripheral monocytes were prepared from both pSS patients and normal individuals. The cells were stimulated in vitro with IFN-γ, and the amounts of IL-6 and soluble BAFF (sBAFF) produced by the cells were quantitated. The effect of sBAFF itself on the production of IL-6 was also studied. To investigate the response of pSS monocytes to these stimuli, the expression levels of the genes encoding BAFF receptors and IL-6-regulating transcription factors were quantitated.
Results: Peripheral pSS monocytes produced significantly higher amounts of sBAFF and IL-6 than normal monocytes did, even in the absence of stimulation. The production of these cytokines was significantly increased upon stimulation with IFN-γ. The elevated production of IL-6 was significantly suppressed by an anti-BAFF antibody. In addition, stimulation of pSS monocytes with sBAFF induced a significant increase in IL-6 production. Moreover, the expression levels of a BAFF receptor and transcription factors regulating IL-6 were significantly elevated in pSS monocytes compared to normal monocytes.
Conclusions: The results of the present study suggest that the mechanisms underlying the production of sBAFF and IL-6 are impaired in pSS monocytes. Our research implies that this impairment is due to abnormally overexpressed IL-6-regulating transcription factors and a BAFF receptor. These abnormalities may cause the development of pSS.
Figures




Comment in
-
How does BAFF activate B cells in patients with autoimmune diseases?Arthritis Res Ther. 2012 Feb 24;14(1):106. doi: 10.1186/ar3729. Arthritis Res Ther. 2012. PMID: 22360881 Free PMC article.
Similar articles
-
Expression of BAFF and BAFF receptors in primary Sjögren's syndrome patients with ectopic germinal center-like structures.Clin Exp Med. 2020 Nov;20(4):615-626. doi: 10.1007/s10238-020-00637-0. Epub 2020 Jun 6. Clin Exp Med. 2020. PMID: 32506205
-
Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.Arthritis Res Ther. 2020 Jun 23;22(1):157. doi: 10.1186/s13075-020-02249-1. Arthritis Res Ther. 2020. PMID: 32576236 Free PMC article.
-
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome.Arthritis Res Ther. 2006;8(2):R51. doi: 10.1186/ar1912. Epub 2006 Feb 28. Arthritis Res Ther. 2006. PMID: 16507175 Free PMC article.
-
Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren's syndrome.Clin Exp Rheumatol. 2019 May-Jun;37 Suppl 118(3):199-208. Epub 2019 Jul 22. Clin Exp Rheumatol. 2019. PMID: 31464677 Review.
-
B-cell hyperactivity in primary Sjögren's syndrome.Expert Rev Clin Immunol. 2014 Apr;10(4):483-99. doi: 10.1586/1744666X.2014.891439. Epub 2014 Feb 25. Expert Rev Clin Immunol. 2014. PMID: 24564507 Review.
Cited by
-
Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.Arthritis Res Ther. 2016 May 14;18(1):106. doi: 10.1186/s13075-016-1006-1. Arthritis Res Ther. 2016. PMID: 27180164 Free PMC article.
-
B-cell activating factor targeted therapy and lupus.Arthritis Res Ther. 2012;14 Suppl 4(Suppl 4):S2. doi: 10.1186/ar3920. Epub 2012 Nov 2. Arthritis Res Ther. 2012. PMID: 23281926 Free PMC article. Review.
-
Sjögren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFβ signaling.Arthritis Res Ther. 2016 May 3;18(1):95. doi: 10.1186/s13075-016-0987-0. Arthritis Res Ther. 2016. PMID: 27142093 Free PMC article.
-
MicroRNAs in Autoimmune Sjögren's Syndrome.Genomics Inform. 2018 Dec;16(4):e19. doi: 10.5808/GI.2018.16.4.e19. Epub 2018 Dec 28. Genomics Inform. 2018. PMID: 30602080 Free PMC article.
-
B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.Arthritis Res Ther. 2013 Oct 28;15(5):R168. doi: 10.1186/ar4352. Arthritis Res Ther. 2013. PMID: 24289101 Free PMC article.
References
-
- Moore PA, Belvedere O, Orr A, Pieri K, LaFleur DW, Feng P, Soppet D, Charters M, Gentz R, Parmelee D, Li Y, Galperina O, Giri J, Roschke V, Nardelli B, Carrell J, Sosnovtseva S, Greenfield W, Ruben SM, Olsen HS, Fikes J, Hilbert DM. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260–263. doi: 10.1126/science.285.5425.260. - DOI - PubMed
-
- Shu HB, Hu WH, Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol. 1999;65:680–683. - PubMed
-
- Schneider P, Mackay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189:1747–1756. doi: 10.1084/jem.189.11.1747. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical